1992
DOI: 10.1016/s0954-6111(06)80220-9
|View full text |Cite
|
Sign up to set email alerts
|

N-acetylcysteine by metered dose inhaler in thetreatment of chronic bronchitis: a multi-centre study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
35
0

Year Published

1997
1997
2015
2015

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 52 publications
(35 citation statements)
references
References 5 publications
0
35
0
Order By: Relevance
“…The reason for this effect is not known but presumably NAC acts as a sink for ROS, which are increased in these patients [1]. However, a multicentre study using NAC delivered by metered dose inhalers in patients with chronic cough failed to show a positive effect on wellbeing, sensation of dyspnoea, cough or lung function [191].…”
Section: N-acetyl-l-cysteinementioning
confidence: 99%
“…The reason for this effect is not known but presumably NAC acts as a sink for ROS, which are increased in these patients [1]. However, a multicentre study using NAC delivered by metered dose inhalers in patients with chronic cough failed to show a positive effect on wellbeing, sensation of dyspnoea, cough or lung function [191].…”
Section: N-acetyl-l-cysteinementioning
confidence: 99%
“…The mechanism for this effect of NAC on H 2 O 2 is not known but presumably NAC acts as a sink for ROS, which are increased in these patients (Rahman, 2005). However, a multicentre study using NAC delivered by metered dose inhalers in patients with chronic cough failed to show a positive effect on wellbeing, sensation of dyspnoea, cough or lung function (Dueholm et al, 1992). Recently, NAC has been shown to downregulate inflammatory responses in CF patients (Tirouvanziam et al, 2006)…”
Section: Therapies/clinical Trials With Gsh Analogsmentioning
confidence: 99%
“…[94][95][96][97] On the other hand, it had relatively minor effects on lung GSH homeostasis. [98][99][100] Both controlled studies and a systematic review with NAC in COPD have shown a small reduction in exacerbations. 101 102 Other compounds with NAC-like activity have been tested in many laboratories including N-acystelyn, GSH esters and GSH precursors, but there are no studies on these compounds in human smokers with COPD.…”
Section: Potential Exogenous Antioxidants and Antioxidant Mimetics Inmentioning
confidence: 99%